Biologics Electronic Reading Room (eFOIA)
The FDA maintains the Biologics Electronic Reading Room (eFOIA) to provide public access to documents across the Vaccines, Blood, and Biologics sections of the Center for Biologics Evaluation and Research (CBER) website.
Stakeholders under the oversight of CBER, including manufacturers of vaccines, blood products, and other biologics, as well as regulatory professionals seeking disclosed agency documents.
The availability of an electronic reading room suggests an effort by CBER to consolidate and streamline access to information typically requested under FOIA. For regulatory professionals, this portal serves as a source for evaluating agency decisions and administrative history, which could potentially aid in benchmarking internal compliance or submission strategies against previously disclosed information.
Regulatory and legal teams should utilize the Biologics eFOIA Reading Room as a centralized repository for researching FDA transparency disclosures related to CBER. Teams may find value in regularly screening these documents to monitor historical regulatory trends or precedents relevant to their specific product categories.
The Biologics eFOI Reading Room provides access to documents posted throughout the "Vaccines, Blood & Biologics" and other sections related to the Center for Biologics Evaluation and Research on the FDA.gov Web site.
Open in openFDA / FDA.gov